Spots Global Cancer Trial Database for DNA Cytometry for Cervical Cancer Screening in China
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: DNA Cytometry for Cervical Cancer Screening in China
Official Title: Comparison of DNA Image Cytometry and Conventional Cytology for Cervical Cancer Screening in China
Study ID: NCT00902551
Conditions
Interventions
Study Description
Brief Summary: Very few screenings of any kind will be possible during a woman's lifetime in most low-resource regions, where 80% of the half-million global cases of cervical cancer occur every year. Although a single round of human papillomavirus (HPV) testing was associated with a significant decline in the rate of advanced cervical cancers and associated deaths, whether other methods like as DNA image cytometry can be used as an more accurate means than others in screening cervical cancer or not is yet to be verified. In addition, the accuracy of both DNA image cytometry and conventional cytology is not well known. The investigators hypothesized that DNA image cytometry was superior in screening cervical cancer than conventional cytology.
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Nanjing Maternal and Child Health Care Hospital, Nanjing, Jiangsu, China
Contact Details
Name: XiaoFeng Shen, MD
Affiliation: Nanjing Medical University
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
